UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate

UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节

基本信息

  • 批准号:
    10263284
  • 负责人:
  • 金额:
    $ 31.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-15 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Control of metabolic flux through the TCA cycle has been investigated dating back many decades. However, there are issues that still require clarification. One important, but largely neglected, issue regards the role of oxaloacetate (OAA) inhibition of succinate dehydrogenase (SDH) in regulating mitochondrial function. Recent findings in my laboratory focused on skeletal muscle mitochondria show that while low membrane potential (ΔΨ) drives respiration, low ΔΨ also initiates a sequence of events leading to mitochondrial OAA accumulation, inhibition of SDH, and consequent inhibition or metabolic “braking” of respiration. Given that low ΔΨ appears to be the initiating factor, the current proposal is focused on the role of OAA in regulating respiration in brown adipose tissue (BAT) wherein ΔΨ is intrinsically low due to the action of uncoupling protein 1 (UCP1). Our overall hypothesis is that mitochondrial OAA metabolism and inhibition of SDH is regulated by definable interactions between UCP1 controlled ΔΨ and downstream events and that there are physiological consequences. Our aims address three issues. Aim 1 will delineate molecular events initiated by UCP1-regulated ΔΨ and culminating in OAA inhibition of O2 flux. Aim 2 examines UCP1 perturbations in live mice to determine if this translates to OAA effects on mitochondrial and cellular function. Aim 3 attempts to modulate OAA inhibition of SDH in a way that may prove beneficial towards mitochondrial, cellular, and whole-body metabolism. To accomplish our objectives, we will use a novel NMR assay to assess mitochondrial OAA content as well as other metabolites. A major reason why our knowledge of OAA effects on respiration is lacking is that OAA is difficult to assay since the metabolite is not stable. In fact, metabolomics services, whether commercial or in university cores, do not offer quantification of OAA. Our research will also use a novel adaptation of existing technology that we developed to assess mitochondrial respiration at clamped concentrations of ADP. In this way, we can assess mitochodnrial respiration beyond the often-determined state 3 and state 4, which are not physiological states. Finally, we will use up-to-date mass spectroscopy methods for targeted metabolite expression and for [13C]isotopomer tracer studies directed at metabolic flux. Our project is applicable to the clinical issue of obesity and its complications since understanding BAT physiology and how it is regulated will add to our overall knowledge of whole-body energetics.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William Irving Sivitz其他文献

William Irving Sivitz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William Irving Sivitz', 18)}}的其他基金

UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
  • 批准号:
    10428630
  • 财政年份:
    2020
  • 资助金额:
    $ 31.5万
  • 项目类别:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
  • 批准号:
    10119128
  • 财政年份:
    2020
  • 资助金额:
    $ 31.5万
  • 项目类别:
UCP1 and the regulation of mitochondrial respiration in brown adipose tissue by oxaloacetate
UCP1 和草酰乙酸对棕色脂肪组织线粒体呼吸的调节
  • 批准号:
    10643873
  • 财政年份:
    2020
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
  • 批准号:
    8262625
  • 财政年份:
    2010
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
  • 批准号:
    8195611
  • 财政年份:
    2010
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
  • 批准号:
    8394599
  • 财政年份:
    2010
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ: Metabolic and Redox Effects and role in Diabetes
线粒体靶向 CoQ:代谢和氧化还原效应及其在糖尿病中的作用
  • 批准号:
    7930312
  • 财政年份:
    2010
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
  • 批准号:
    8974234
  • 财政年份:
    2009
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
  • 批准号:
    8734547
  • 财政年份:
    2009
  • 资助金额:
    $ 31.5万
  • 项目类别:
Mitochondrial-targeted CoQ analogs: Bioenergetic Effects in Obesity
线粒体靶向 CoQ 类似物:肥胖的生物能效应
  • 批准号:
    8883094
  • 财政年份:
    2009
  • 资助金额:
    $ 31.5万
  • 项目类别:

相似国自然基金

相似海外基金

New development of cellular regeneration therapy in jaw bone using stem cells derived from adipocytes jaw bone
利用颌骨脂肪细胞来源的干细胞进行颌骨细胞再生治疗的新进展
  • 批准号:
    23K16058
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel mechanism of insulin resistance mediated by uric acid metabolism in adipocytes
脂肪细胞尿酸代谢介导胰岛素抵抗的新机制
  • 批准号:
    23K10969
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
  • 批准号:
    10751284
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
Development of adipocytes for gene therapy that avoids cellular stress due to overexpression of therapeutic proteins
开发用于基因治疗的脂肪细胞,避免因治疗蛋白过度表达而造成的细胞应激
  • 批准号:
    23H03065
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of bitter taste receptors in adipocytes and hepatocytes
脂肪细胞和肝细胞中苦味受体的功能分析
  • 批准号:
    23K05107
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of mechanisms for conversion of adipocytes to cancer-associated fibroblasts in osteosarcoma microenvironment
阐明骨肉瘤微环境中脂肪细胞转化为癌症相关成纤维细胞的机制
  • 批准号:
    23K19518
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study on UCP-1 independent metabolic regulation by brown adipocytes
棕色脂肪细胞对UCP-1独立代谢调节的研究
  • 批准号:
    23K18303
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis
脂肪细胞中的 NKA/CD36 信号传导促进氧化应激并驱动动脉粥样硬化的慢性炎症
  • 批准号:
    10655793
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
The mechanisms of the signal transduction from brown adipocytes to afferent neurons and its significance.
棕色脂肪细胞向传入神经元的信号转导机制及其意义。
  • 批准号:
    23K05594
  • 财政年份:
    2023
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
NKT cell activation depend on lipid accumulation in adipocytes
NKT 细胞的激活取决于脂肪细胞中的脂质积累
  • 批准号:
    22K08679
  • 财政年份:
    2022
  • 资助金额:
    $ 31.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了